Last reviewed · How we verify

NCT06612983: (IASTM)

Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Gait

Completed NA Last updated 25 September 2024
What this trial tests

NA trial testing Instrument Assisted Soft Tissue Mobilization in Healthy in 70 participants. Completed in 28 February 2023.

Timeline
9 January 2023
Primary endpoint
28 February 2023
28 February 2023

Quick facts

Lead sponsorBeth Marschner
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment70
Start date9 January 2023
Primary completion28 February 2023
Estimated completion28 February 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Beth Marschner

Who can join

18 and older, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy tissue of adult volunteers. The main questions it aims to answer are: * Does IASTM treatment have an effect on range of motion (ROM) as measured in the ankle and knee? * Does IASTM treatment have an effect on movement patterns including gait - how a person walks? Researchers will compare pre-test and post-test data from the same individual on their day with treatment to the pre-test and post-test data from the same individual on their day without treatment to see if ROM or gait are effected by use of IASTM. Participants will: * Complete a past medical and injury history questionnaire * Have ankle and knee range of motion (ROM) measurements taken on both lower extremities using a goniometer * Undergo a gait analysis to determine center of gravity, center of pressure, step length, stride length, and stride frequency using Noraxon MyoMuscle Ultium Insoles * Undergo IASTM treatment techniques using the HawkGrips tools including applying emollient to the skin to reduce friction on the surface followed by scanning the gastroc/soleus complexes and Achilles tendons using the HG8-Scanner tool for 15 strokes in each direction to identify areas of concern, then the concave tool corresponding to the size of the structure being treated will be used (HG6-Large Multi-Curve, HG5-Medium Multi-Curve, HG4-Small Multi-Curve) for 15 strokes in each direction. Treatment techniques should last for 10 minutes in total on each side. * Complete the ankle and knee ROM measurements as well as gait analysis again to document progress at the end of the first session. * Return three to seven days after the first session in which the subject will have the walking treatment. * Undergo the same baseline pre-test measurements for range of motion and gait analysis as the first session * Experience the walking treatment by walking for the same time period that the IASTM treatment took at the first session * Undergo the post-test range of motion and gait analysis for data comparison.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Instrument Assisted Soft Tissue Mobilization

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Beth Marschner trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06612983.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing